Bioelectronics Corp (BIEL)

[Duke2484]

"Duke, you have to understand that period was pre FDA approval. The product or company was being evaluated by many during that period. We are now in a different era post FDA approval."

That "period" was 14 years! Look at the price action and continued toxic financing... what exactly is different post FDA approval here?

"Expect revenues to increase as Actipatch becomes a household name, and investors fight for shares. Everything is timing. The timing now is on investors' side. Hence, this stock is grossly undervalued!"

Sure, revenues may increase but the hole here for investors is deep and getting deeper everyday. The OS is probably around 20 billion now, no one is or will be "fighting for shares".